Are There Shortages and Regional Disparities in Lecanemab Treatment Facilities? A Cross-Sectional Study
Introduction: Alzheimer disease (AD) is the most common type of dementia, affecting 70% of patients with dementia. In Japan, over 5 million people aged 65 years and older had dementia in 2018, and this figure is expected to rise to 25% to 30% of this age group by 2045. In Japan, lecanemab, which was...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2024-11-01
|
| Series: | Health Services Insights |
| Online Access: | https://doi.org/10.1177/11786329241299312 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|